4D MOLECULAR THERAPEUTICS IN (FDMT) Stock News
USA - NASDAQ:FDMT - US35104E1001 - Common Stock
12.27 USD
+0.93 (+8.2%)
12.03 USD
-0.24 (-1.96%)
FDMT Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Benzinga
10 days ago - By: 4D Molecular Therapeutics, Inc.
10 days ago - By: 4D Molecular Therapeutics, Inc.
13 days ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: Benzinga
13 days ago - By: 4D Molecular Therapeutics, Inc.
14 days ago - By: 4D Molecular Therapeutics, Inc.
14 days ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: Zacks Investment Research - Mentions: SPRY
3 months ago - By: The Motley Fool
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.